This statistic shows the number of biopharma medicines in development as of May 2018, by therapeutic category. As of that moment, 1,120 medicines were in development for cancer and cancer-related conditions in the United States.
- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Pharmaceuticals: biopharma medicines in development 2018 by category
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*
Exclusive Premium Statistic
This statistic shows the number of biopharma medicines in development as of May 2018, by therapeutic category. As of that moment, 1,120 medicines were in development for cancer and cancer-related conditions in the United States.
Exclusive content
Exclusive Premium statistic
Get a Premium Account for unrestrained access.
Benefits of our Premium membership:
- Access to all Premium statistics
- Download as XLS, PNG and PDF
- Detailed source and background information
Premium Account
$49 per month*
(billed annually)
(billed annually)
| Number of medicines | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Number of medicines | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive content
Exclusive Premium statistic
Get a Premium Account for unrestrained access.
Benefits of our Premium membership:
- Access to all Premium statistics
- Download as XLS, PNG and PDF
- Detailed source and background information
Premium Account
$49 per month*
(billed annually)
(billed annually)
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the number of biopharma medicines in development as of May 2018, by therapeutic category. As of that moment, 1,120 medicines were in development for cancer and cancer-related conditions in the United States.
Show more- Show sources information
- Show publisher information
- Release date
- July 2018
- Region
- United States
- Survey time period
- as of May 2018
- Supplementary notes
- * Medicines are defined as single products that are counted exactly once regardless of the number of indications pursued.
- Open this statistic in...
More information
- Region
- United States
- Survey time period
- as of May 2018
- Supplementary notes
- * Medicines are defined as single products that are counted exactly once regardless of the number of indications pursued.
- Open this statistic in...
Other interesting statistics
+
+Top pharmaceutical companies located in Canada by revenue 2016
+
+World pharmaceutical sales 2015-2017 by region
+
+Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
+
+Pfizer's total revenue 2006-2017
+
+Johnson & Johnson's total revenue 2005-2017
+
+Leading countries in life sciences sector M&As HY1 2018
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax
(New York residents only).
Prices do not include sales tax
(New York residents only).
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Biotech industry
- 92 page/s
- English
- pptx
- Detailed references
Everything On "Biotech industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "U.S. pharmaceutical industry"
- Contribution to global pharma
The most important statistics
- Distribution of the total global pharmaceutical market sales from 2014 to 2017, by submarket*World pharmaceutical market distribution by submarket 2014-2017
- Global pharmaceutical sales from 2015 to 2017, by region (in billion U.S. dollars)*World pharmaceutical sales 2015-2017 by region
- Market share of top 10 national pharmaceutical markets worldwide in 2016*Market share of the leading 10 global pharmaceutical markets 2016
- Growth of top 10 national pharmaceutical markets worldwide from 2011 to 2016*Top 10 global pharmaceutical markets: growth 2011-2016
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
- Leading countries in global life sciences mergers and acquisitions in 1st half of 2018Leading countries in life sciences sector M&As HY1 2018
- Overview
The most important statistics
- Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*U.S. total medicine spending 2002-2016
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)Leading therapy areas for U.S. drug spending 2016
- Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*U.S. top 20 prescribed drugs based on sales 2016
- Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)Top U.S. pharma products by prescriptions 2016
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)Pharmaceutical channel distribution by U.S. spending 2014-2016
- U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*Pharmaceutical preparation manufacturing gross output 1998-2016
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2017
- Companies
The most important statistics
- 2018 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*2018 list of top U.S. biotech and pharmaceutical companies based on revenue
- Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*Pharmaceutical corporations by U.S. revenue 2016
- Johnson & Johnson's total revenue from 2005 to 2017 (in million U.S. dollars)Johnson & Johnson's total revenue 2005-2017
- Pfizer's total revenue from 2006 to 2017 (in million U.S. dollars)Pfizer's total revenue 2006-2017
- Total revenue of Merck & Co. from 2006 to 2017 (in million U.S. dollars)Merck & Co - total revenue 2006-2017
- Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)Ad spending of pharmaceutical companies in the U.S. 2015
- Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*Highest pharmaceutical company penalties in the U.S. 2012-2015
- Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)Top pharmaceutical companies located in Canada by revenue 2016
- Research and development
The most important statistics
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*Research and development expenditure: U.S. pharmaceutical industry 1995-2017
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017U.S. pharma industry R&D spending as a percent of total revenues 1990-2017
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*Pharmaceuticals: biopharma medicines in development 2018 by category
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*Pharmaceuticals: cost of drug development in the U.S. since 1975
- Number of new molecular entities launched in the U.S. from 2003 to 2015Number of new drugs launched in the U.S. 2003-2015
- Number of FDA approved orphan designations in the United States from 2000 to 2014Number of FDA approved orphan designations in the U.S. 2000-2014
- New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)U.S. sales growth of new brand medicines 2011-2015
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2014R&D expenditure per employee in U.S. sectors 2000-2014
- Generics
The most important statistics
- Top 20 companies based on unbranded generics U.S. market share during 2014-2015*Market share of unbranded generics by top 20 companies in U.S. 2014-2015
- Change in branded and generic medication spending in the United States from 2009 to 2015 (in billion U.S. dollars)Spending change on branded and generic medicines in the U.S. 2009-2015
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016U.S. brand and generic prescription drug revenue 2005-2016
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016Branded vs. generic U.S. drug prescriptions dispensed 2005-2016
- Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)Savings through generic drug usage in the U.S. 2008-2017
- Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*Biggest selling drugs with patent at threat in the U.S. in 2017, by revenue
- Outlook
The most important statistics
- Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by regionForecast of CAGR global pharmaceutical industry by region 2015-2018
- Forecast of global medicine spending distribution in 2020, by region*Global spending on medicines by regional share forecast 2020
- Projected global pharmaceutical sales for 2021, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2021
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*Top branded biologic drugs in the U.S. that will go generic by 2028
- Projected top 25 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)Leading U.S. pharmaceutical products by revenue 2024
- Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2019 (in billion U.S. dollars)Healthcare and pharmaceutical industry digital ad spend in the U.S. 2011-2019
- The consumer's view
The most important statistics
- How is your overall impression of the U.S. pharma industry?U.S. adults impression of the U.S. pharma industry
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?U.S. adults that believe physicians are under pressure from pharma to prescribe drugs
- How would you rate the U.S. pharma companies concerning the quality of their drugs?U.S. adults impression of the U.S. pharma drug qualities
- How would you rate the U.S. pharma companies concerning their fairness towards patients?U.S. adults impression of the U.S. pharma companies fairness towards patients
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017U.S. adults who would rate selected pharma features as excellent or good 2017
- Which of these pharma companies do you prefer when buying drugs?Preferred pharma companies by Americans for drug purchase 2017
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*Americans on US pharma quality compared to foreign pharma 2017
Popular Related Keywords
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Prescription medicines: U.S. spending growth 1999-2016
- U.S. healthcare: consumer responses to viewing advertisements for medicines
- Small molecules facing loss of developed market exclusivity 2011-2020
- New medicine availability by therapy area in the U.S. 2013
- Medicinal market growth worldwide including rebates 2009-2018
- Medicine spending share globally in 2007,2017 and 2022, by country group
- Biologics share of global pharmaceutical spending 2002-2017
- Medicine doses consumed globally by region 2015 and 2020 forecast
- Medicinal market growth by world region, specialty and traditional 2013-2018
- U.S. insured patients' out-of-pocket health spending 2008-2011
- New medicine availability by therapy area worldwide 2013
- Most abused prescription drugs by dispensed prescriptions U.S. 2013
- Latin America: biopharmaceuticals revenue 2016-2021
- Changes in prescriptions for older people in the U.S. 2011
- Changes in prescriptions for U.S. young adults
- Total biopharmaceutical revenue worldwide 2006-2011
- Italy: market value of biopharmaceuticals 2017, by type
- Italy: average prices of biosimilars and originators 2016-2017
- Italy: estimated market value of biosimilars 2018-2022, by type
- Italy: market value of medical biological products 2017, by molecule
Studies
- Personalized medicine
- Patented Medicine Prices Review Board - Annual Report 2016
- Prescribing for Diabetes, England 2005/06 to 2015/16
- Complementary Medicines Australia 2017/18 Federal pre-Budget Submission
- Egenvårdsmarknaden 2016
- Antibiotic use in the United Kingdom (UK)
- Pharmaceutical trends in Europe
- Pharmaceutical industry in the Netherlands
- Oncology
- CDER New Drugs Program: 2017 Update
- CDER 2017 New Drug Therapy Approvals
- 2014 Regional Report - Complementary Medicines in Australia
- Targeted Use of Complementary Medicines: Potential Health Outcomes & Cost Savings in Austr...
- Alternative Health Therapies in Australia (May 2014)
- Prescription Cost Analysis, England 2014
Statistics on the topic
Free statistics
- U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*
- Number of new molecular entities launched in the U.S. from 2003 to 2015
- Number of FDA approved orphan designations in the United States from 2000 to 2014
- New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2014
- Change in branded and generic medication spending in the United States from 2009 to 2015 (in billion U.S. dollars)
- Forecast of global medicine spending distribution in 2020, by region*
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*
- How is your overall impression of the U.S. pharma industry?
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017
- Which of these pharma companies do you prefer when buying drugs?
- Spending growth for prescription medicines in the U.S. from 1999 to 2016*
- Biologics share of total global pharmaceutical spending from 2002 and 2017
- Largest changes in medical prescriptions for older people in the U.S. in 2011 (per 1,000 population)
- Largest changes in medical prescriptions for young adults in the U.S. in 2011* (per 1,000 population)
- Total biopharmaceutical revenue worldwide from 2006 to 2011 (in billion U.S. dollars)
Premium Statistics
- Distribution of the total global pharmaceutical market sales from 2014 to 2017, by submarket*
- Global pharmaceutical sales from 2015 to 2017, by region (in billion U.S. dollars)*
- Market share of top 10 national pharmaceutical markets worldwide in 2016*
- Growth of top 10 national pharmaceutical markets worldwide from 2011 to 2016*
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)
- Leading countries in global life sciences mergers and acquisitions in 1st half of 2018
- Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)
- Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*
- Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)
- 2018 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*
- Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*
- Johnson & Johnson's total revenue from 2005 to 2017 (in million U.S. dollars)
- Pfizer's total revenue from 2006 to 2017 (in million U.S. dollars)
- Total revenue of Merck & Co. from 2006 to 2017 (in million U.S. dollars)
- Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)
- Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*
- Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*
- Top 20 companies based on unbranded generics U.S. market share during 2014-2015*
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016
- Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)
- Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*
- Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by region
- Projected global pharmaceutical sales for 2021, by region (in billion U.S. dollars)*
- Projected top 25 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)
- Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2019 (in billion U.S. dollars)
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?
- How would you rate the U.S. pharma companies concerning the quality of their drugs?
- How would you rate the U.S. pharma companies concerning their fairness towards patients?
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*
- Consumer responses to viewing advertisements for medicines
- Loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020 (in billion U.S. dollars)
- New molecular entities availability in the United States as of 2013, by therapy area*
- Global medicinal market growth including rebates from 2009 to 2018 (in billion U.S. dollars)
- Global medicine spending distribution in 2007, 2017 and 2022, by country group
- Global medicines doses consumed by region in 2015 and 2020 forecast (in billion standard units)
- Projected distribution of global medicinal market growth from 2013 to 2018, by region and type of medicine*
- Insured patients' out-of-pocket costs in the U.S. from 2008 to 2011 (in billion U.S. dollars)
- New molecular entities availability worldwide as of 2013, by therapy area
- Leading 10 abused prescription drugs in the U.S. by total number of dispensed prescriptions in 2013
- Biopharmaceuticals market value in Latin America in 2016 and 2021 (in billion U.S. dollars)
- Market value of biopharmaceuticals becoming off-patent between 2017 and 2022 in Italy as of 2017, by type (in million euros)
- Average prices of biosimilars and originators in Italy in May 2016 and December 2017 (in euros)
- Estimated market value of biosimilars in Italy between 2018 and 2022, by type of originator*
- Market value of medical biological products* in Italy in 2017, by molecule (in million euros)
Statista Accounts: Access All Statistics. Starting from $588 / Year
Topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Exclusive Premium functionality
Register in seconds and access exclusive features.
- Full access:
To this and over 1 million additional datasets - Save Time:
Downloads allow integration with your project - Valid data:
Access to all sources and background information
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
5 News
Latest News
New
New Statista Study: European Football Benchmark
Just in time for the start of the new Premier League season, Statista launches the European Football Benchmark: The first football study that compares the 5 big European leagues from a fan's perspective. Find out everything about the Premier League, its clubs, sponsors and fans.
New
New tutorial video on the Global Consumer Survey
The Statista Global Consumer Survey offers a global perspective on consumption and media usage, covering the offline and online world of the consumer. The new tutorial video shows all functionalities and illustrates how you can use the DIY analysis tool effectively.
New
Consumer Electronics Report 2018 out now!
Market reports for the Statista Consumer Market Outlook will now be released roughly every other week starting with the Consumer Electronics Report 2018. The market reports include data as well as qualitative insights into market drivers, consumer behaviour, trends, sales channels and key players.
Updated
In-depth eMobility Report updated & extended
The trend topic eMobility affects many industries and constantly attracts new players. Our updated in-depth report contains all relevant data and insights and includes an excel file with a detailed list of electric cars, trucks, cargo vehicles, buses, and their specifications.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.